![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 35, 36698-36707, August 27, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





¶
**
From the
Department of Biochemistry and Molecular Genetics and the ||Section of Rheumatology, University of Illinois, Chicago, Illinois 60607 and the
Department of Pharmacology, University of Illinois, Chicago, Illinois 60612
The tumor suppressor protein ARF (alternate reading frame) inhibits MDM2 to stabilize and activate the functions of p53. Here we provide evidence for an additional activity of ARF that attenuates cell cycle progression independently of p53 activation. We show that ARF interacts with c-Myc independently of MDM2 or p53. Consequently, ARF relocalizes c-Myc from the nucleoplasm to the nucleolus. Binding and relocalization by ARF correlate with an inhibition of the c-Myc-activated transcription in both p53-positive and -negative cells. Using inducible cell lines, we show that the wild type ARF, but not a mutant, inhibits expression of the c-Myc-induced genes before inhibiting S phase. Moreover, ARF inhibits Myc-induced progression into S phase in cells lacking p53 or expressing a defective p53, indicating that ARF inhibits the S phase stimulatory function of c-Myc independently of p53. Our results strongly suggest that cMyc is a bona fide target of ARF and that ARF attenuates c-Myc independently of the ARF-p53 axis.
Received for publication, November 10, 2003 , and in revised form, May 28, 2004.
* This work was supported by NCI, National Institutes of Health, Grants CA88863 and CA100035 (to P. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Supported by National Institutes of Health Grants GM54709 and CA55079.
** To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Genetics (M/C 669), University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607. Tel.: 312-413-0255; Fax: 312-355-3847; E-mail: Pradip{at}uic.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
O. Yogev, K. Saadon, S. Anzi, K. Inoue, and E. Shaulian DNA Damage-Dependent Translocation of B23 and p19ARF Is Regulated by the Jun N-Terminal Kinase Pathway Cancer Res., March 1, 2008; 68(5): 1398 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Benanti, M. L. Wang, H. E. Myers, K. L. Robinson, C. Grandori, and D. A. Galloway Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc Mol. Cancer Res., November 1, 2007; 5(11): 1181 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Morton, T. Kantidakis, and R. J. White RNA polymerase III transcription is repressed in response to the tumour suppressor ARF Nucleic Acids Res., May 14, 2007; 35(9): 3046 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Tompkins, J. Hagen, A. A. Frazier, T. Lushnikova, M. P. Fitzgerald, A. di Tommaso, V. Ladeveze, F. E. Domann, C. M. Eischen, and D. E. Quelle A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability J. Biol. Chem., January 12, 2007; 282(2): 1322 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rizos, H. A. McKenzie, A. L. Ayub, S. Woodruff, T. M. Becker, L. L. Scurr, J. Stahl, and R. F. Kefford Physical and Functional Interaction of the p14ARF Tumor Suppressor with Ribosomes J. Biol. Chem., December 8, 2006; 281(49): 38080 - 38088. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paliwal, S. Pande, R. C. Kovi, N. E. Sharpless, N. Bardeesy, and S. R. Grossman Targeting of C-Terminal Binding Protein (CtBP) by ARF Results in p53-Independent Apoptosis. Mol. Cell. Biol., March 1, 2006; 26(6): 2360 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Kalin, I-C. Wang, T. J. Ackerson, M. L. Major, C. J. Detrisac, V. V. Kalinichenko, A. Lyubimov, and R. H. Costa Increased Levels of the FoxM1 Transcription Factor Accelerate Development and Progression of Prostate Carcinomas in both TRAMP and LADY Transgenic Mice Cancer Res., February 1, 2006; 66(3): 1712 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Sanders and P. A. Gruppuso Coordinated regulation of c-Myc and Max in rat liver development Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G145 - G155. [Abstract] [Full Text] [PDF] |
||||
![]() |
I-C. Wang, Y.-J. Chen, D. Hughes, V. Petrovic, M. L. Major, H. J. Park, Y. Tan, T. Ackerson, and R. H. Costa Forkhead Box M1 Regulates the Transcriptional Network of Genes Essential for Mitotic Progression and Genes Encoding the SCF (Skp2-Cks1) Ubiquitin Ligase Mol. Cell. Biol., December 15, 2005; 25(24): 10875 - 10894. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Datta, J. Sen, J. Hagen, C. K. Korgaonkar, M. Caffrey, D. E. Quelle, D. E. Hughes, T. J. Ackerson, R. H. Costa, and P. Raychaudhuri ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF Mol. Cell. Biol., September 15, 2005; 25(18): 8024 - 8036. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tago, S. Chiocca, and C. J. Sherr Sumoylation induced by the Arf tumor suppressor: A p53-independent function PNAS, May 24, 2005; 102(21): 7689 - 7694. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.J. SHERR, D. BERTWISTLE, W. DEN BESTEN, M.-L. KUO, M. SUGIMOTO, K. TAGO, R.T. WILLIAMS, F. ZINDY, and M.F. ROUSSEL p53-Dependent and -Independent Functions of the Arf Tumor Suppressor Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 129 - 137. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |